
What We’re Reading: Respiratory Virus Travel Testing; Ketamine for Hard-to-Treat Pain; ACA Enrollment for 2023
CDC plans to monitor over 30 pathogens in high-risk airports; a surge in ketamine prescriptions raises questions about safety and oversight; changes to come in Affordable Care Act (ACA) enrollment for 2023.
CDC Expands Traveler-Based Surveillance Program to Include Respiratory Virus Testing
The CDC is set to enhance its traveler-based surveillance program by adding respiratory virus testing,
Ketamine's Rise as a Treatment for Hard-to-Treat Pain Sparks Concerns
As opioid painkiller prescriptions decline in the United States, ketamine is emerging as a new option for managing hard-to-treat pain and mental health conditions,
What You Need to Know About This Year's ACA Enrollment
The open enrollment period for health insurance plans through the Affordable Care Act (ACA) marketplace is underway, offering new features and potential benefits for prospective customers,
Related to this article








